Patents by Inventor Kumar RAMESH

Kumar RAMESH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10130620
    Abstract: The present invention relates to a liquid pharmaceutical composition for oral administration comprising fexofenadine and/or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable carrier which is either polyethylene glycol or a propylene glycol-based solvent, or a mixture thereof, from 35 to 90% wt. of a pharmaceutical excipient stabilizing fexofenadine and/or a pharmaceutically acceptable salt thereof, said pharmaceutical excipient consisting of glycerol with optionally sorbitol. The invention also relates to the uses of these compositions as a medicament and to the process for preparing said compositions.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: November 20, 2018
    Assignee: AVENTISUB LLC
    Inventors: Kumar Amith, Prajapati Dilip, Prasad Kum, Khullar Praveen, Kumar Ramesh
  • Patent number: 9814680
    Abstract: The present invention relates to an oral pharmaceutical fixed dose composition in a form of a dispersible tablet for use in the treatment of tuberculosis, said oral pharmaceutical composition comprising: a) granules comprising isoniazid and at least one intragranular excipient, b) granules comprising rifapentine and at least one intragranular excipient, and c) at least one extragranular excipient, and to its process of preparation.
    Type: Grant
    Filed: July 22, 2014
    Date of Patent: November 14, 2017
    Assignee: SANOFI
    Inventors: Prajapati Dilip, Prasad Kum, Khullar Praveen, Kumar Ramesh, Kumar Shakti
  • Publication number: 20160184231
    Abstract: The present invention relates to an oral pharmaceutical fixed dose composition in a form of a dispersible tablet for use in the treatment of tuberculosis, said oral pharmaceutical composition comprising: a) granules comprising isoniazid and at least one intragranular excipient, b) granules comprising rifapentine and at least one intragranular excipient, and c) at least one extragranular excipient, and to its process of preparation.
    Type: Application
    Filed: July 22, 2014
    Publication date: June 30, 2016
    Inventors: Prajapati DILIP, Prasad KUM, Khullar PRAVEEN, Kumar RAMESH, Kumar SHAKIT
  • Publication number: 20160184284
    Abstract: The present invention relates to a liquid pharmaceutical composition for oral administration comprising fexofenadine and/or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable carrier which is either polyethylene glycol or a propylene glycol-based solvent, or a mixture thereof, from 35 to 90% wt. of a pharmaceutical excipient stabilizing fexofenadine and/or a pharmaceutically acceptable salt thereof, said pharmaceutical excipient consisting of glycerol with optionally sorbitol. The invention also relates to the uses of these compositions as a medicament and to the process for preparing said compositions.
    Type: Application
    Filed: July 1, 2014
    Publication date: June 30, 2016
    Inventors: Kumar AMITH, Prajapati DILIP, Prasad KUM, Khullar PRAVEEN, Kumar RAMESH
  • Publication number: 20160158157
    Abstract: The present invention relates to an oral pharmaceutical fixed dose composition for use in the treatment of tuberculosis, said oral pharmaceutical composition comprising: a) granules comprising isoniazid and at least one intragranular excipient, b) granules comprising rifapentine and at least one intragranular excipient, and c) at least one extragranular excipient, and to its process of preparation.
    Type: Application
    Filed: July 22, 2014
    Publication date: June 9, 2016
    Inventors: Prajapati DILIP, Prasad KUM, Khullar PRAVEEN, Kumar RAMESH, Kumar SHAKTI